Today: 21 July 2026
Adobe stock price slides on AI disruption jitters; investors look to March earnings call

Adobe stock price slides on AI disruption jitters; investors look to March earnings call

New York, Feb 3, 2026, 15:21 EST — Regular session

  • Adobe shares dropped roughly 7% in afternoon trading, deepening the sell-off in software stocks
  • Anthropic’s latest AI legal tool has reignited concerns over competition and shrinking margins throughout the industry
  • Adobe will report earnings on March 12, providing a crucial update on demand and how it’s monetising AI

Adobe shares dropped Tuesday amid a late-session surge in selling across software stocks.

The Photoshop maker dropped $20.76, roughly 7.1%, to $272.62 in afternoon trading, having hit a session low of $271.11 earlier.

The sell-off hit software stocks hard, with investors questioning if artificial intelligence might shake up the competitive landscape sooner than anticipated. “We’re looking at a lot of software names … that may well be disrupted,” said Art Hogan, chief market strategist at B. Riley Wealth. Reuters

This is crucial now as the “AI winners” trade faces scrutiny during a packed earnings week, with investors growing hesitant to overpay for long-term growth plays vulnerable to being replicated or undercut. Generative AI churns out text, images, and code, raising concerns it could erode the value of previously reliable tools.

Traders and analysts pointed to Anthropic’s rollout of a legal plug-in for its Claude chatbot as a key trigger, fueling the debate over AI shifting from infrastructure to direct rivalry with established software and data providers. “The software companies were assumed to be winners from AI,” noted Lars Skovgaard, senior investment strategist at Danske Bank. Reuters

Adobe grabbed headlines this week with a focused update. Starting March 1, new customers won’t be able to download Adobe Animate anymore. Support will continue until 2027 for most users, while enterprise clients get an extended runway until 2029.

Shareholders are gearing up for Adobe’s fiscal 2026 Q1 earnings call on March 12. The key focus: whether demand remains steady and if AI tools are genuinely boosting sales instead of just inflating expenses.

Risks remain. Rapid advances in AI tools might ramp up price pressure across segments of Adobe’s creative and document software lines, with some customers holding off on upgrades to try out less expensive options. And a barrage of headlines can drown out the company’s core fundamentals for extended stretches.

Traders remain keyed in on whether the software sector can steady before the close and what upcoming tech earnings reveal about spending and rivalry. For Adobe, the next major date is March 12.

Khadija Saeed is a financial markets reporter at TS2.tech, specializing in stocks, technology and emerging industries. She studied economics and finance at the London School of Economics and previously worked in market research before moving into financial journalism. Her coverage focuses on the companies, innovations and economic trends influencing global investors. Follow Khadija Saeed on Google News.

Stock Market Today

  • Goodwin PLC (GDWN.L): 27.50% Revenue Jump, ROE Stands Out in Diversified Sectors
    July 21, 2026, 12:41 AM EDT. Goodwin PLC (GDWN.L) posts 27.50% revenue growth alongside a strong 35.15% return on equity (ROE), reflecting efficient management. Shares last traded at 17,540 GBp, within a 52-week range of 7,440 to 27,600 GBp. Despite edging down 0.02%, the company maintains an EPS of 5.27 and a 1.57% dividend yield, underscoring ongoing profitability. With analyst ratings and P/E data unavailable, Goodwin's presence in naval defense, nuclear decommissioning, and petrochemicals continues to set it apart in the industrial sector.
Danaher stock price jumps 2% to $223 as DHR snaps losing streak in late trade
Previous Story

Danaher stock price jumps 2% to $223 as DHR snaps losing streak in late trade

Abbott (ABT) stock slips on FDA warning letter over FreeStyle Libre testing; dates to watch
Next Story

Abbott (ABT) stock slips on FDA warning letter over FreeStyle Libre testing; dates to watch

Go toTop